HORSHAM, Pa., April 2, 2012 /PRNewswire/ -- Grammy®-nominated singer, songwriter, producer and prostate cancer survivor Charlie Wilson and Janssen Biotech, Inc. are teaming up on Making Awareness a Priority: Putting Prostate Cancer on the M.A.P., a new program designed to raise awareness among African-American men and their families about prostate cancer and its disproportionate impact on the African-American community. With the highest incidence of prostate cancer of any race in the U.S., African-American men are 2.4 times more likely to die from the disease than Caucasian men. Making Awareness a Priority (M.A.P.) brings together leading voices in advocacy and health education through live events in select cities across the country.
In recognition of National Minority Health Month and National Minority Cancer Awareness Week, the program kicks off on April 21 in Atlanta, Georgia with program resources available online at My Prostate Cancer Roadmap® (www.myprostatecancerroadmap.com).
Charlie Wilson was diagnosed with prostate cancer in 2008. "At first, I never wanted to talk about my cancer. Then I realized that after spending a lot of my life performing, it was time to start informing. That's why I am continuing to raise my voice to help those with prostate cancer by joining with Janssen Biotech, Inc. in the Making Awareness a Priority program – to encourage African-American men to understand their risk factors for prostate cancer and start a conversation with their loved ones and doctors about this serious and deadly disease."
The average annual prostate cancer incidence rate in the U.S. was 60% higher in African-American men than in Caucasian men between 2003 and 2007. Factors including family history, access to medical
|SOURCE Janssen Biotech, Inc.|
Copyright©2010 PR Newswire.
All rights reserved